COVID-19 drops to 10th leading cause of death as U.S. mortality rates fall in 2023

Provisional 2023 U.S. mortality data show COVID-19 as the 10th leading cause of death, with the highest overall mortality rates among non-Hispanic Black individuals.

Adaptimmune taps Galapagos to decentralize manufacturing of solid tumor T cell therapy

Adaptimmune Therapeutics and Galapagos have formed an alliance to manufacture a clinical-stage solid cancer asset in a decentralized way. At the center of the deal

June 1, 2024

23ME610 by 23AndMe Holding for Merkel Cell Carcinoma: Likelihood of Approval

23ME610 is under clinical development by 23andMe Holding and currently in Phase II for Merkel Cell Carcinoma.

February 22, 2024

Voters fret high medical bills are being ignored by presidential rivals

Tom Zawierucha, 58, a building services worker in New Jersey, wishes candidates would talk more about protecting older Americans from big medical bills.

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.